Cover Image

New Multitarget Rivastigmine-Indole Hybrids as Potential Drug Candidates for Alzheimer's Disease

Alzheimer's disease (AD) is the most common form of dementia with no cure so far, probably due to the complexity of this multifactorial disease with diverse processes associated with its origin and progress. Several neuropathological hallmarks have been identified that encourage the search for...

Full description

Saved in:

Bibliographic Details
Main Authors:	Leo Bon (Author), Angelika Banaś (Author), Inês Dias (Author), Inês Melo-Marques (Author), Sandra M. Cardoso (Author), Sílvia Chaves (Author), M. Amélia Santos (Author)
Format:	Book
Published:	MDPI AG, 2024-02-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Design, Synthesis, In Silico Studies and In Vitro Evaluation of New Indole- and/or Donepezil-like Hybrids as Multitarget-Directed Agents for Alzheimer's Disease
by: Violina T. Angelova, et al.
Published: (2023)

Development of novel salicylic acid-donepezil-rivastigmine hybrids as multifunctional agents for the treatment of Alzheimer's disease
by: Yi Zhou, et al.
Published: (2023)

Donepezil structure-based hybrids as potential multifunctional anti-Alzheimer's drug candidates
by: Luca Piemontese, et al.
Published: (2018)

Novel multitarget-directed tacrine derivatives as potential candidates for the treatment of Alzheimer's disease
by: Wen-Yu Wu, et al.
Published: (2017)

Once-daily transdermal rivastigmine in the treatment of Alzheimer’s disease
by: Andreas Wentrup, et al.
Published: (2008)

Novel tacrine-benzofuran hybrids as potential multi-target drug candidates for the treatment of Alzheimer's Disease
by: Gaia Fancellu, et al.
Published: (2020)

Formulation and characterization of polymeric nanoparticle of Rivastigmine for effective management of Alzheimer's disease
by: Faisal Imam, et al.
Published: (2024)

Comparative study of rivastigmine and galantamine on the transgenic Drosophila model of Alzheimer's disease
by: Yasir Hasan Siddique, et al.
Published: (2022)

Marine Natural Products, Multitarget Therapy and Repurposed Agents in Alzheimer's Disease
by: Márcia Martins, et al.
Published: (2020)

Acquired Localized Hypertrichosis Induced by Rivastigmine
by: Adrian Imbernón-Moya, et al.
Published: (2016)

From Single Target to Multitarget/Network Therapeutics in Alzheimer's Therapy
by: Hailin Zheng, et al.
Published: (2014)

Novel benzothiazole derivatives as multitargeted-directed ligands for the treatment of Alzheimer's disease
by: Donia E. Hafez, et al.
Published: (2023)

QT interval prolongation and with donepezil, rivastigmine and galantamine
by: Katie Malone, et al.
Published: (2020)

Antistaphylococcal evaluation of indole–naphthalene hybrid analogs
by: Ashraf K, et al.
Published: (2019)

Unveiling the Multitarget Anti-Alzheimer Drug Discovery Landscape: A Bibliometric Analysis
by: Anna Sampietro, et al.
Published: (2022)

Cytotoxic and antibacterial polyketide-indole hybrids synthesized from indole-3-carbinol by Daldinia eschscholzii
by: Liping Lin, et al.
Published: (2019)

Gossypol and Its Natural Derivatives: Multitargeted Phytochemicals as Potential Drug Candidates for Oncologic Diseases
by: Dilipkumar Pal, et al.
Published: (2022)

Synthesis, Antiplasmodial, and Antileukemia Activity of Dihydroartemisinin-HDAC Inhibitor Hybrids as Multitarget Drugs
by: Lukas von Bredow, et al.
Published: (2022)

Identification of Potential Multitarget Compounds against Alzheimer's Disease through Pharmacophore-Based Virtual Screening
by: Géssica Oliveira Mendes, et al.
Published: (2023)

Design and synthesis of new indole drug candidates to treat Alzheimer's disease and targeting neuro-inflammation using a multi-target-directed ligand (MTDL) strategy
by: Phoebe F. Lamie, et al.
Published: (2022)

New Indole-3-Propionic Acid and 5-Methoxy-Indole Carboxylic Acid Derived Hydrazone Hybrids as Multifunctional Neuroprotectors
by: Neda Anastassova, et al.
Published: (2023)

Alantolactone: A Potential Multitarget Drug candidate for Prevention of SARS-CoV-2 Cell Entry
by: Erum Zafar, et al.
Published: (2022)

Multitargeting approaches involving carbonic anhydrase inhibitors: hybrid drugs against a variety of disorders
by: Claudiu T. Supuran
Published: (2021)

The Potential Effect of Insulin on AChE and Its Interactions with Rivastigmine In Vitro
by: Tahereh Jamshidnejad-Tosaramandani, et al.
Published: (2021)

Effects of Rivastigmine and Donepezil on Brain Acetylcholine Levels in Acetylcholinesterase-Deficient Mice
by: Runa S. Naik, et al.
Published: (2009)

Polymeric Microneedles for Transdermal Delivery of Rivastigmine: Design and Application in Skin Mimetic Model
by: Tânia M. T. Guimarães, et al.
Published: (2022)

Curcumin-Piperlongumine Hybrids with a Multitarget Profile Elicit Neuroprotection in In Vitro Models of Oxidative Stress and Hyperphosphorylation
by: Ángel Cores, et al.
Published: (2021)

Multitarget Activities of Kleeb Bua Daeng, a Thai Traditional Herbal Formula, Against Alzheimer's Disease
by: Chantha Chheng, et al.
Published: (2020)

Study of the multitarget mechanism of Astragalus (HUANGQI) in the treatment of Alzheimer's disease based on network pharmacology and molecular docking technology
by: Feng Lv, et al.
Published: (2024)

Novel multitarget analgesic candidate SZV-1287 demonstrates potential disease-modifying effects in the monoiodoacetate-induced osteoarthritis mouse model
by: Ádám István Horváth, et al.
Published: (2024)

High-Throughput Screening and Molecular Dynamics Simulation of Natural Product-like Compounds against Alzheimer's Disease through Multitarget Approach
by: Danish Iqbal, et al.
Published: (2021)

Consensus Ensemble Multitarget Neural Network Model of Anxiolytic Activity of Chemical Compounds and Its Use for Multitarget Pharmacophore Design
by: Pavel M. Vassiliev, et al.
Published: (2023)

Identification of Indazole-Based Thiadiazole-Bearing Thiazolidinone Hybrid Derivatives: Theoretical and Computational Approaches to Develop Promising Anti-Alzheimer's Candidates
by: Yousaf Khan, et al.
Published: (2023)

Candidate Therapeutics by Screening for Multitargeting Ligands: Combining the CB2 Receptor With CB1, PPARγ and 5-HT4 Receptors
by: Shayma El-Atawneh, et al.
Published: (2022)

In Situ<i>-</i>Forming Microparticles for Controlled Release of Rivastigmine: In Vitro Optimization and In Vivo Evaluation
by: Mohamed Haider, et al.
Published: (2021)

Novel Multitarget Hydroxamic Acids with a Natural Origin CAP Group against Alzheimer's Disease: Synthesis, Docking and Biological Evaluation
by: Margarita Neganova, et al.
Published: (2021)

Stepwise Structural Simplification of the Dihydroxyanthraquinone Moiety of a Multitarget Rhein-Based Anti-Alzheimer Lead to Improve Drug Metabolism and Pharmacokinetic Properties
by: Caterina Pont, et al.
Published: (2024)

Some Candidate Drugs for Pharmacotherapy of Alzheimer's Disease
by: Barbara Miziak, et al.
Published: (2021)

Pharmacomodulations around an anti-Alzheimer drug-candidate
by: Sylvain Marc, et al.
Published: (2022)

Biological exploration of a novel 1,2,4-triazole-indole hybrid molecule as antifungal agent
by: Fabrice Pagniez, et al.
Published: (2020)